On Monday, Firstmerit Corp (NASDAQ:FMER)’s shares declined -0.16% to $18.71.
FirstMerit Corporation (FMER) signed a Planned Partnership agreement with The U.S. Department of Commerce – International Trade Administration. As a Planned Partner, FirstMerit will support the International Trade Administration’s mission of broadening and deepening the U.S. exporter base.
FirstMerit’s International Banking Division offers U.S. companies a comprehensive range of products and services to assist them enter and compete in global markets, counting letters of credit, documentary collections, foreign exchange advisory and payments services and U.S. government-guaranteed working capital loan programs. These services are delivered through practiced bankers, state-of-the-market technology and global banking partners.
FirstMerit Corporation operates as the bank holding company for FirstMerit Bank N.A. that provides various banking, fiduciary, financial, insurance, and investment services to corporate, institutional, and individual customers. The company’s Commercial segment offers commercial term loans, revolving credit arrangements, asset-based lending, leasing, commercial mortgages, real estate construction lending, and letters of credit, in addition to treasury administration, government banking, international banking, merchant card, and other depository products and services.
Laboratory Corp. of America Holdings (NYSE:LH)’s shares gained 0.05% to $127.35.
Laboratory Corporation of America® Holdings (LH) declared that Deborah Keller will succeed Joseph Herring as Chief Executive Officer of Covance Drug Development (Covance). Mr. Herring will retire on July 31 after more than a decade as CEO.
Ms. Keller joined Covance in 1987 and has held senior leadership roles in global operations, quality assurance, and marketing over her tenure. Most recently she served as Executive Vice President, Covance and Group President, R&D Laboratories, where she led the combined central laboratory and early development laboratory organizations of more than 6,000 employees at 18 facilities across the globe. As CEO of Covance, Ms. Keller will also be a member of the LabCorp Executive Committee and will report to David P. King, Chairman and CEO of LabCorp.
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, STD tests, HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by the medical profession in core testing, patient diagnosis, and in the monitoring and treatment of diseases.
At the end of Monday s trade, Jabil Circuit, Inc. (NYSE:JBL)‘s shares dipped -1.33% to $19.98.
Jabil Circuit, Inc. (JBL) declared that its Board of Directors has authorized the repurchase of up to $100 million worth of shares of the Company’s common stock during the period from recently through August 31, 2016. The shares will be repurchased from time-to-time in the open market at the Company’s discretion and subject to market conditions and other factors.
Jabil Circuit, Inc., together with its auxiliaries, provides electronic manufacturing services and solutions worldwide. It offers electronics design, production, and product administration services to companies in the aerospace, automotive, computing, defense, digital home, energy, healthcare, industrial, instrumentation, lifestyles, mobility, mold, networking, packaging, peripherals, storage, telecommunications, and wearable technology industries.
ITT Corp (NYSE:ITT), ended its Monday’s trading session with -2.55% loss, and closed at $37.03.
ITT Corporation (ITT) stated 2015 second-quarter financial results, counting stronger operating margins and earnings per share growth, that reflected net operating productivity, restructuring savings from proactive actions and effective cost containment in a challenging macroeconomic environment.
On a GAAP basis, the company delivered revenue of $628 million in the second quarter, reflecting a 5 percent decline, primarily due to unfavorable foreign exchange. GAAP segment operating margins expanded 90 basis points to 14.3 percent. Second-quarter GAAP EPS raised to $1.56, contrast with $0.44 in the preceding year, primarily due to the recognition of a $101 million pre-tax benefit, or $0.70 per share, associated with implementing a new single-firm asbestos defense strategy.
ITT Corporation manufactures and sells engineered critical components and customized technology solutions for the energy, transportation, and industrial markets worldwide. The company operates in four segments: Industrial Process, Motion Technologies, Interconnect Solutions, and Control Technologies. The Industrial Process segment manufactures industrial pumps, valves, and related equipment comprising centrifugal, chemical, slurry and process, and paper stock pumps, in addition to vertical, axial flow, multi-stage, and other pumps; twin screw, multiphase boosting system, and progressive cavity pumps; and industrial knife-gate and sanitary diaphragm valves.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
